|
 |
AmlodipineThis page contains recent news articles, when available, and an overview of Amlodipine but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Amlodipine (when available) Zolmitriptan is a selective 5-hydroxytryptamine receptor subtype agonist indicated for the acute treatment of migraine attacks with or without aura in adults. Zolmitriptan is not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine. Zolmitriptan is an agonist for a vascular 5-hydroxytryptamine receptor subtype (probably a member of the 5-HT1D family) having only a weak affinity for 5-HT1A, 5-HT5A, and 5-HT7 receptors and no significant affinity or pharmacological activity at 5-HT2, 5-HT3 or 5-HT4 receptor subtypes or at alpha1-, alpha2-, or beta-adrenergic, dopamine1,; dopamine2; muscarinic, or benzodiazepine receptors. This action in humans correlates with the relief of migraine headache. In addition to causing vasoconstriction, experimental data from animal studies show that Zolmitriptan also activates 5-HT1 receptors on peripheral terminals of the trigeminal nerve innervating cranial blood vessels, which may also contribute to the antimigrainous effect of Zolmitriptan in humans. For the acute treatment of adult migraine (with or without auras) Mechanism Of Action: Zolmitriptan binds with high affinity to human 5-HT1B and 5-HT1D receptors leading to cranial blood vessel constriction. Current theories proposed to explain the etiology of migraine headache suggest that symptoms are due to local cranial vasodilatation and/or to the release of sensory neuropeptides (vasoactive intestinal peptide, substance P and calcitonin gene-related peptide) through nerve endings in the trigeminal system. The therapeutic activity of zolmitriptan for the treatment of migraine headache can most likely be attributed to the agonist effects at the 5HT1B/1D receptors on intracranial blood vessels (including the arterio-venous anastomoses) and sensory nerves of the trigeminal system which result in cranial vessel constriction and inhibition of pro-inflammatory neuropeptide release. News Articles on Zolmitriptan Medicines are not usually culprit in gas production - 02 Jun 2008 I was surprised to find that Lipitor, amlodipine and atenolol had gas production listed as one of their side effects. I can't believe that this is a common SouthCoastToday.com, Simultaneous Initiation of Therapy With Amlodipine/Atorvastatin ... - May 20, 2008 Patients qualified for the study were randomised to either amlodipine/atorvastatin (5/20 mg daily) plus TLC or to placebo plus TLC for 8 weeks. DG News Amlodipine Plus Valsartan Reduces Blood Pressure Reductions Better ... - May 15, 2008 By Betty S. Riggs NEW ORLEANS -- May 15, 2008 -- In black patients with stage 2 hypertension, combination therapy with amlodipine and valsartan produced a DG News Exforge cuts black patients' blood pressure -Novartis - May 14, 2008 Exforge, a combination of leading high blood pressure medicines Diovan and amlodipine, produced a significant decrease in blood pressure after only two Reuters Significant Blood Pressure Reductions Seen In Difficult-to-Treat ... - May 16, 2008 Exforge, a combination of the world's leading high blood pressure medicines Diovan® (valsartan) and amlodipine, produced a significant decrease in blood Medical News Today (press release), Azor(TM) Reduces Blood Pressure In Difficult To Treat Special ... - May 16, 2008 Since the vasodilation attributable to amlodipine in AZOR is gradual in onset, acute hypotension has rarely been reported after oral administration. Medical News Today (press release), Aurobindoharma recieves approval from MCC - May 11, 2008 These products with an estimated generic market size of ZAR 165 million in the local market include Auro - Lisinopril Co, Auro-Amlodipine, Business Standard, Ranbaxy gets Japan approval for generic amlodipine tablets - Apr 8, 2008 Pfizer Inc. (nyse: PFE - news - people )'s patent on amlodipine-based Norvasc, used in treating hypertension and angina, expired in 2007. Forbes, Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the ... - May 12, 2008 Daiichi Sankyo's fixed-dose combination of two antihypertensives, the calcium channel blocker amlodipine besylate and the angiotensin receptor blocker Earthtimes (press release), Hypertension Treatment In Elderly Patients Over 80 Years Of Age ... - May 26, 2008 The ACCOMPLISH trial was the first to compare the combination of an angiotensin converting enzyme inhibitor with a calcium blocker (benazepril /amlodipine, Medical News Today (press release), When is the right time to take your pills? - May 25, 2008 A Chinese study found that taking a calcium channel-blocker drug, amlodipine, had a better effect when given at 7 am than at 7 pm Noon: Osteoarthritis The News - International, Par Pharmaceutical Reports First Quarter 2008 Results - May 8, 2008 Niravam(R) and 2 mg Amlodipine + 5/40 and 10/40 Lotrel(R) Benazepril Capsules mg Propafenone ER 225, 325, and Rythmol(R) Capsules 425 mg SR Nateglinide Trading Markets (press release), Plain tales from the surgery - May 23, 2008 Following a visit to a hypertensive elderly patient I was trying to add the following sentence to her notes: 'I have added amlodipine 5mg tablets. Healthcare Republic Cardiovascular Drug Discoveries 2008 Reveals Insight into Leading ... - May 22, 2008 In terms of revenue, Pfizer’s Norvasc (amlodipine) was the leading hypertension treatment for several years, up to 2006 when its sales peaked at US$4866 Business Wire (press release), CCB/ACE Inhibitor Dual Therapy for Hypertension Lowers ... - May 20, 2008 Patients were randomly assigned to receive a pill containing both benazepril (an ACE inhibitor) and amlodipine (a CCB) or a pill containing both benazepril Journal of American Medical Association (subscription), Mylan Reports Adjusted Diluted EPS of $0.09 for the Quarter Ended ... - May 8, 2008 Additionally, current quarter margins were negatively impacted by competition due to the loss of exclusivity on certain products including amlodipine, CNNMoney.com (press release) Forest Laboratories, Inc. (FRX) Study Demonstrates Lexapro(R ... - May 8, 2008 In addition to our growing product line, Forest also co-promotes the Daiichi Sankyo, Inc. product Azor(TM)* (amlodipine and olmesartan medoxomil), Lifescience-online, USPTO Confirms Validity of Lipitor Patent - May 7, 2008 Lipitor and Caduet, which combines Lipitor with Pfizer’s hypertension drug Norvasc (amlodipine besylate), until after two of its process patents expire. FDA news (subscription), Teva Reports First Quarter 2008 Results - May 5, 2008 Quarterly sales benefited primarily from sales of generic versions of Protonix® (pantoprazole) and Lotrel® (amlodipine besylate/benazepril) which were Business Wire (press release), Lupin's Japanese arm gets nod for 10 products - 23 Apr 2008 Amlodipine is the largest molecule in Japan, with sales of over JPY 184 billion as per IMS 2007. Kyowa plans to aggressively market this product through its Economic Times, Ranbaxy gets Japanese Health Ministry nod for Amlodipine - Apr 8, 2008 Amlodipine tablets has been approved for the strengths 2.5 mg and 5 mg. Amlodipine has a market size of around two billion dollars and is currently the Hindu, India Ranbaxy launches generic amlodipine in Japan - Apr 8, 2008 Amlodipine has a market of about $2 billion in Japan, and represents the biggest generic opportunity in that market, Ranbaxy said in a statement. Reuters Ranbaxy gets Japan approval for generic amlodipine tablets - Apr 8, 2008 Pfizer Inc.'s (NYSE:PFE) patent on amlodipine-based Norvasc, used in treating hypertension and angina, expired in 2007. The copying, republication or CNNMoney.com Ranbaxy to market Amlodipine tablets in Japan - Apr 8, 2008 MUMBAI: Ranbaxy Laboratories has received its first approval from Ministry of Health and Labour Welfare of Japan for marketing the generic of Amlodipine Economic Times, Ranbaxy gains Japanese approval for sale of amlodipine - Apr 10, 2008 To mitigate against these losses Pfizer launched Caduet (amlodipine and atorvastatin), a product coupling blood pressure and cholesterol control which In-PharmaTechnologist.com, Ranbaxy to sell Amlodipine tablets in Japan - Apr 8, 2008 Amlodipine has the unique distinction of being the first product developed by any foreign generic pharma company outside Japan and subsequently being India Infoline.com, Pfizer: Federal court in Canada upholds Pfizer's Norvasc patent - Apr 17, 2008 The court issued an order prohibiting regulatory approval of Pharmascience's proposed product in Canada until Pfizer's amlodipine besylate patent expires in CNNMoney.com Atorvastatin as Effective as Amlodipine for Reducing Ischaemia in ... - Apr 2, 2008 By Bruce Sylvester CHICAGO -- April 2, 2008 -- Atorvastatin monotherapy is as effective as amlodipine monotherapy and a combination of the two drugs for DG News ACCOMPLISH: Amlodipine/benazepril combo lowered CVD morbidity ... - Mar 31, 2008 CHICAGO - Combination therapy of amlodipine and benazepril in single-tablet form was effective for the treatment of high-risk patients with hypertension, Endocrine Today, Adamed enters Finland - Apr 17, 2008 Adamed, the Polish drug manufacturer, will enter a new foreign market in May with the launch of its flagship amlodipine-based cardiological drug in Finland. Polish Market, Ranbaxy drug gets Japan’s nod - Apr 9, 2008 Amlodipine is the first independent product approval received by company in Japan and also has the distinction of being the first product developed by any Sify, Ranbaxy's net profit at USD 39mn (Rs 1530 mn), + 19% - Apr 22, 2008 Amlodipine tablets has a market size of approximately USD 2 Billion (Jan-Dec' 2007 - IMS - Japan). For Q1, the Company achieved Consolidated Sales of Rs. Moneycontrol.com (press release), Ranbaxy gets Japan approval for generic amlodipine tablets - Apr 8, 2008 Pfizer Inc. (nyse: PFE - news - people )'s patent on amlodipine-based Norvasc, used in treating hypertension and angina, expired in 2007. Forbes, Uganda: Is Uganda Safe From India's Fake Drugs? - Apr 21, 2008 I have been checking on anti- hypertension drugs that are available on the Uganda market, and I have discovered that a 10mg tablet of Amlodipine from AllAfrica.com, Ranbaxy receives Japanese authorisation for product development ... - Apr 8, 2008 Ranbaxy says amlodipine tablet is the first independent product approval received by Ranbaxy in Japan is the first product developed by any foreign generic domain-B, Blood pressure drugs reduce heart risk - Apr 1, 2008 One study showed amlodipine, a calcium channel blocker, helped more patients against heart events and stroke than a diuretic when they were used along with Food Consumer, Studies highlight existing BP meds - Apr 1, 2008 Another study showed that an ACE inhibitor combined with a calcium channel blocker--in this case benazepril and amlodipine--outperformed an ACE inhibitor FiercePharma, Hypertension Drugs Effective in Elderly - Apr 1, 2008 Although combined pills have been used before, such as a daily pill containing benazepril and a calcium channel blocker, amlodipine, the new study looked at Enews 2.0, Ranbaxy gets Japanese nod for blood pressure drug - Apr 8, 2008 The company said Tuesday that MHLW’s authorisation for Ranbaxy’s generic Amlodipine 2.5 mg and 5 mg tablets make the hypertensive medicine the first of its Thaindian.com, Two-drug Blood Pressure Therapy Dramatically Lowers Cardiovascular ... - Mar 31, 2008 One group received a tablet containing benazepril, which is a type of drug called an ACE inhibitor, and amlodipine, which belongs to a class of drugs known Science Daily (press release) Sigma Annual Report to shareholders - Apr 20, 2008 ...(Amlodipine) and Xyvion (Tibolone) has seen Sigma's the Reforms will bring to all industry participants. portfolio of generics continue to increase. Sydney Morning Herald, ACCOMPLISH: ACE inhibitor plus calcium-channel blocker best for ... - Mar 31, 2008 ...therapy—the ACE inhibitor benazepril plus the calcium-channel blocker amlodipine—was more effective than treatment with the ACE inhibitor plus diuretic. TheHeart.Org, Indian pharma cos making inroads into Japan - Apr 14, 2008 Glochem got regulatory approval for Amlodipine Besilate (of which the company is the world’s largest producer) in Japan in March 2008. Hindu Business Line, * Novartis on track in 2008: - Apr 20, 2008 Exforge (USD 72 million), the first single-tablet combination of an angiotensin receptor blocker (Diovan) with the calcium channel blocker amlodipine, Market Wire (press release) Pfizer earnings suffer as patent expiries cause more damage - Apr 18, 2008 ...for market share with other therapies such as Merck & Co rival statin Zocor (simvastatin), while Norvasc (amlodipine) sales slumped 52% to $513 million. Pharma Times (subscription), Glochem into formulations, looking for PE funds - Apr 11, 2008 The Hyderabad-based Glochem, manufacturer of amlodipine besalate, has acquired 5 acres of land in the upcoming pharma SEZ (special economic zone) in Hindu Business Line, ACC: Calcium Channel Blocker Beats Diuretic for Initial BP Combo ... - Apr 1, 2008 Single pill, fixed-dose tablets containing amlodipine (Norvasc) and the ace inhibitor benazepril (Lotensin) reduced cardiovascular mortality and morbidity MedPage Today, Lipitor Provided an Unexpectedly Potent Heart Benefit in Patients ... - Apr 1, 2008 The DUAAL study was a randomized, double-blind, multi-country study comparing Lipitor (n=103), Norvasc ® (amlodipine besylate) (n=104) and a combination of Business Wire (press release), Lotrel, a Single-Pill Combination for Treating High Blood Pressure ... - Mar 31, 2008 ...high blood pressure patients treated with Lotrel(R) (amlodipine besylate and benazepril HCl) had 20% fewer cardiovascular events than those taking a CNNMoney.com (press release) Novartis reports higher sales and - Apr 20, 2008 Exforge (USD 72 million), the first single-tablet combination of anangiotensin receptor blocker (Diovan) with the calcium channelblocker amlodipine, Ad-Hoc-News (Pressemitteilung), The Effect of Drugs from Novartis and Sanofi-Aventis on Mortality ... - Apr 2, 2008 ...that Novartis's Tekturna HCT, Novartis's Exforge and Sanofi-Aventis's ilepatril all have advantages in this attribute over sales- leading amlodipine. FOXBusiness A behavioural sign I can call my own - Apr 15, 2008 ...by self-medicating with Special Brew). But then I noticed the same with other drugs. ‘This amlodipine may give you ankle swelling, flushing and headache.’ Pulse, Genes affect blood pressure treatment - Apr 15, 2008 People with a different version of the gene improved more when taking amlodipine. This drug comes from a different family of blood pressure medicines. Gather.com, Blood Pressure Drugs Lower Heart Risk - Apr 1, 2008 ...daily pill combining a diuretic and the ACE inhibitor benazepril versus a daily pill containing benazepril and a calcium channel blocker, amlodipine. The Associated Press Combo pill cuts blood pressure and heart risks - Mar 31, 2008 Lotrel combines benazepril with amlodipine besylate, the active ingredient in Pfizer Inc's calcium channel blocker Norvasc. In the other, benazepril was Reuters Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in ... - Mar 31, 2008 ...who have not achieved an adequate response with other antianginal drugs, and should be used in combination with amlodipine, beta-blockers or nitrates. FOXBusiness Ranbaxy`s Amlodipine tablets receive authorization from MHLW-Japan - Apr 8, 2008 Ranbaxy Laboratories received authorization from Ministry of Health and Labour Welfare (MHLW-Japan) for marketing the generic version of Amlodipine tablets Myiris.com, Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter ... - Apr 15, 2008 In addition to our growing product line, Forest also co-promotes the Daiichi Sankyo, Inc. product Azor(TM)* (amlodipine and olmesartan medoxomil), PR Newswire (press release), Buy Ranbaxy - Apr 10, 2008 Besides, Ranbaxy Laboratories has received authorization from Ministry of Health and Labour Welfare of Japan for marketing the generic version of amlodipine TopNews, Pharma Blog Watch - Apr 7, 2008 ...inhibitor benazepril plus the calcium-channel blocker amlodipine — was more effective than treatment with the ACE inhibitor plus diuretic,â€? Goldberg writes. FDA news (subscription), The Outlook for the Cardiovascular Disorders Market Remains Robust ... - Apr 7, 2008 ...payors and physicians will favour Merck’s Vytorin/Inegy and Novartis’ newly launched combination product Exforge (amlodipine/losartan) -Empty pipelines. Earthtimes, Market Report -- In Play (PFE) - Apr 17, 2008 Federal Court in Canada upholds Pfizer's Norvasc patent decision prevents launch of generic Amlodipine Besylate product by Pharmascience until 2010 Co MSN Money This Week in Health - Apr 4, 2008 ...pill containing benazepril and a calcium channel blocker, amlodipine in over 11400 people, age 58 on average, in the United States and Nordic countries. Intelihealth.com, Study Challenges Standard of Care For Patients With Hypertension ... - Apr 4, 2008 In a late-breaking clinical trial session, Dr. Jamerson noted that the purpose of the study was to determine whether amlodipine besylate/benazepril would be DG News ACCOMPLISH study proves to be a win-win for Novartis - Apr 1, 2008 The study randomised over 11000 patients to two Novartis fixed-dose combinations: Lotrel (amlodipine/benazepril) and Lotensin HCT Pharma Times (subscription), Pfizer Inc Says Canada Court Upholds Norvasc Patent - Apr 17, 2008 Pfizer Inc. (PFE) said a Canadian Federal Court upheld its patent covering amlodipine besylate, the active ingredient in its hypertension drug Norvasc. CNNMoney.com What's going to be hot at ACC 2008? - Mar 26, 2008 ...randomized to combination treatment with the ACE inhibitor benazepril and a diuretic or to benazepril and a calcium-channel blocker (CCB)—amlodipine. TheHeart.Org, Ranbaxy Becomes First Foreign Generic Company to Develop a Generic ... - Apr 8, 2008 Amlodipine Tablet is the first independent product approval received by Ranbaxy in Japan. It has the unique distinction of being the first product developed Prdomain Business Register (press release), New Blood Pressure Treatments Launched - Apr 10, 2008 Calcium channel blockers (most of the commonly used ones end in '-ipine', like Amlodipine and Nifedipine. These can cause swollen ankles and flushing ACE Sky News, Brand Names/Synonyms: Amlodipine is also known by the following brand names and/or synonymsAMLODIPINE BESYLATE, 99%; Amlocard; Amlodipine; Amlodipine Benzenesulfonate; Amlodipine Besilate; Amlodipine Besylate; Amlodipine Free Base; Amlodipino [Spanish]; Amlodipinum [Latin]; Amlodis; Amvaz; CHEMBANK1767; Coroval; Lipinox; Lotrel; Norvasc Drug Category: Amlodipine is categorized under the following by the FDA: Vasodilator Agents; Antianginal; Antihypertensive Agents; Calcium Channel Blockers; ATC:C08CA01 Dosage Forms: white tablets equivalent to 2.5, 5 and 10 mg Absorption: Amlodipine is slowly and almost completely absorbed from the gastrointestinal tract. Interactions: -->Interactions for Amlodipine: In vitro data indicate that NORVASC has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on NORVASC. CIMETIDINE: Co-administration of NORVASC with cimetidine did not alter the pharmacokinetics of NORVASC. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine. MAALOX (antacid): Co-administration of the antacid Maalox with a single dose of NORVASC had no significant effect on the pharmacokinetics of NORVASC. SILDENAFIL: A single 100 mg dose of sildenafil (ViagraÒ) in subjects with essential hypertension had no effect on the pharmacokinetic parameters of NORVASC. When NORVASC and sildenafil were used in combination, each agent independently exerted its own blood pressure lowering effect. Effect of NORVASC on other agents. ATORVASTATIN: Co-administration of multiple 10 mg doses of NORVASC with 80 mg of atorvastatin resulted in no significant change in the steady state pharmacokinetic parameters of atorvastatin. DIGOXIN: Co-administration of NORVASC with digoxin did not change serum digoxin levels or digoxin renal clearance in normal volunteers. ETHANOL (alcohol): Single and multiple 10 mg doses of NORVASC had no significant effect on the pharmacokinetics of ethanol. WARFARIN: Co-administration of NORVASC with warfarin did not change the warfarin prothrombin response time. In clinical trials, NORVASC has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Drug/Laboratory Test Interactions: None known. Chemical IUPAC Name: methylethyl2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |